Churg-Strauss syndrome

G. Ramakrishna, David Eric Midthun

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Objectives: This article discusses the clinical manifestations and treatment protocols of Churg-Strauss syndrome (CSS). A review of the definition, pathophysiology, and prognosis of CSS is included, as well as more recent evidence of the presumed association between antileukotriene antagonists and CSS. Data sources: Relevant articles in the medical literature derived from searching the MEDLINE database (1966 to present) with key terms Churg-Strauss syndrome, allergic granulomatosis, and allergic granulomatous angiitis. Sources included review articles, meta-analyses, randomized control trials, case reports, case series, and seminal articles, the majority of which had been published within the past decade. Study selection: Studies that described the clinical manifestations, pathophysiology, etiology, treatment, or prognosis of CSS. Results: CSS is a systemic vasculitic disorder with multiorgan involvement and diverse presentations. Conclusions: Recognition of the multiorgan manifestations of CSS is crucial to clinical management. Whether a causal relationship exists between antileukotriene antagonists and onset of CSS remains unclear.

Original languageEnglish (US)
Pages (from-to)603-613
Number of pages11
JournalAnnals of Allergy, Asthma and Immunology
Volume86
Issue number6
StatePublished - 2001

Fingerprint

Churg-Strauss Syndrome
Clinical Protocols
Information Storage and Retrieval
MEDLINE
Meta-Analysis
Databases

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Churg-Strauss syndrome. / Ramakrishna, G.; Midthun, David Eric.

In: Annals of Allergy, Asthma and Immunology, Vol. 86, No. 6, 2001, p. 603-613.

Research output: Contribution to journalArticle

Ramakrishna, G & Midthun, DE 2001, 'Churg-Strauss syndrome', Annals of Allergy, Asthma and Immunology, vol. 86, no. 6, pp. 603-613.
Ramakrishna, G. ; Midthun, David Eric. / Churg-Strauss syndrome. In: Annals of Allergy, Asthma and Immunology. 2001 ; Vol. 86, No. 6. pp. 603-613.
@article{a3c7bf40f255499d9b6451a5e37e8e91,
title = "Churg-Strauss syndrome",
abstract = "Objectives: This article discusses the clinical manifestations and treatment protocols of Churg-Strauss syndrome (CSS). A review of the definition, pathophysiology, and prognosis of CSS is included, as well as more recent evidence of the presumed association between antileukotriene antagonists and CSS. Data sources: Relevant articles in the medical literature derived from searching the MEDLINE database (1966 to present) with key terms Churg-Strauss syndrome, allergic granulomatosis, and allergic granulomatous angiitis. Sources included review articles, meta-analyses, randomized control trials, case reports, case series, and seminal articles, the majority of which had been published within the past decade. Study selection: Studies that described the clinical manifestations, pathophysiology, etiology, treatment, or prognosis of CSS. Results: CSS is a systemic vasculitic disorder with multiorgan involvement and diverse presentations. Conclusions: Recognition of the multiorgan manifestations of CSS is crucial to clinical management. Whether a causal relationship exists between antileukotriene antagonists and onset of CSS remains unclear.",
author = "G. Ramakrishna and Midthun, {David Eric}",
year = "2001",
language = "English (US)",
volume = "86",
pages = "603--613",
journal = "Annals of Allergy, Asthma and Immunology",
issn = "1081-1206",
publisher = "American College of Allergy, Asthma and Immunology",
number = "6",

}

TY - JOUR

T1 - Churg-Strauss syndrome

AU - Ramakrishna, G.

AU - Midthun, David Eric

PY - 2001

Y1 - 2001

N2 - Objectives: This article discusses the clinical manifestations and treatment protocols of Churg-Strauss syndrome (CSS). A review of the definition, pathophysiology, and prognosis of CSS is included, as well as more recent evidence of the presumed association between antileukotriene antagonists and CSS. Data sources: Relevant articles in the medical literature derived from searching the MEDLINE database (1966 to present) with key terms Churg-Strauss syndrome, allergic granulomatosis, and allergic granulomatous angiitis. Sources included review articles, meta-analyses, randomized control trials, case reports, case series, and seminal articles, the majority of which had been published within the past decade. Study selection: Studies that described the clinical manifestations, pathophysiology, etiology, treatment, or prognosis of CSS. Results: CSS is a systemic vasculitic disorder with multiorgan involvement and diverse presentations. Conclusions: Recognition of the multiorgan manifestations of CSS is crucial to clinical management. Whether a causal relationship exists between antileukotriene antagonists and onset of CSS remains unclear.

AB - Objectives: This article discusses the clinical manifestations and treatment protocols of Churg-Strauss syndrome (CSS). A review of the definition, pathophysiology, and prognosis of CSS is included, as well as more recent evidence of the presumed association between antileukotriene antagonists and CSS. Data sources: Relevant articles in the medical literature derived from searching the MEDLINE database (1966 to present) with key terms Churg-Strauss syndrome, allergic granulomatosis, and allergic granulomatous angiitis. Sources included review articles, meta-analyses, randomized control trials, case reports, case series, and seminal articles, the majority of which had been published within the past decade. Study selection: Studies that described the clinical manifestations, pathophysiology, etiology, treatment, or prognosis of CSS. Results: CSS is a systemic vasculitic disorder with multiorgan involvement and diverse presentations. Conclusions: Recognition of the multiorgan manifestations of CSS is crucial to clinical management. Whether a causal relationship exists between antileukotriene antagonists and onset of CSS remains unclear.

UR - http://www.scopus.com/inward/record.url?scp=0034979079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034979079&partnerID=8YFLogxK

M3 - Article

C2 - 11428732

AN - SCOPUS:0034979079

VL - 86

SP - 603

EP - 613

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

SN - 1081-1206

IS - 6

ER -